Delivery Order SPE2DB25D2207-SPE2DB25FQQBE

Award Date 12/30/24
Potential Completion Date 12/31/24
Potential Value $1.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of Prilosec DR 2.5 mg suspension 30s to the Defense Logistics Agency (DLA), a defense agency of the U.S. government. The contract, valued at $2,105.68, was awarded to Amerisourcebergen Drug Corp, a subsidiary of the major pharmaceutical distribution company Amerisourcebergen Corporation. Amerisourcebergen holds a single-award Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31,...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The $54,180.05 firm-fixed-price delivery order is for the supply of Prilosec DR 10 mg Suspension, a pharmaceutical product. The contract has a period of performance through September 20, 2023 and does not include any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora,...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Prilosec DR 10 mg Suspension, a prescription medication, with a ceiling value of $10,532.34 and a performance period through July 10, 2023. The contract is a firm fixed-price delivery order and is not designated as a set-aside. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the...
This federal contract award is for the delivery of Prilosec DR 10 mg suspension to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The contract was awarded to the Corporate Office division of Amerisourcebergen Drug Corp, a major pharmaceutical distributor, and has a ceiling value of $2,498.94. The contract is a Delivery Order with a Firm Fixed Price pricing type, and the ultimate completion date is May 3, 2024. The contract did not have a set-aside...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,475.62 Delivery Order (SPE2DB23FRVD2) is for the supply of 30 suspension packages of the drug Prilosec 10 mg. The contract has a firm fixed price and an ultimate completion date of August 17, 2023. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $4,799.06 firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distributor. This contract is to supply Prilosec DR 10 mg suspension, a prescription medication, with a completion date of February 6, 2024. Amerisourcebergen Drug Corp is the prime contractor and there are no set-aside designations mentioned. This delivery order...
This federal contract award is a delivery order (SPE2DB23FRPK7) issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $1,318.60 firm fixed-price contract is for the delivery of PRILOSEC DR 10 MG SUSPENSION 30S, a pharmaceutical product. The contract has no set-aside designation, indicating it was awarded through full and open competition. Amerisourcebergen Drug Corp, a major pharmaceutical distributor, holds a...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $1,974.48 for the supply of PRILOSEC DR 2.5 MG SUSPENSION 30S. The award was made by the Defense Logistics Agency (DLA), a defense agency, and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves...
This federal contract award, issued by the Defense Logistics Agency (DLA), was granted to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,048.74 firm fixed-price delivery order is for 4,564,839,898 units of Omeprazole DR 20 mg capsules. The contract has an ultimate completion date of June 10, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,330.80 firm fixed price delivery order is for the supply of 100 count capsules of 40 mg Omeprazole DR, a medication used for gastric conditions. The award has an ultimate completion date of October 31, 2024 and is not designated as a set-aside contract. Amerisourcebergen holds a $999,999,999 Indefinite...
  • SPE2DB25D2207
    Indefinite Delivery Contract
  • SPE2DB25D2207-SPE2DB25FQQBE
    Delivery Order

This federal contract award, valued at $1,386.87, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Prilosec DR 10 mg suspension, a prescription medication.

This contract award is associated with a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract encompasses critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains.

The contract award does not have a set-aside designation, indicating open competition. Amerisourcebergen is the prime contractor, and there is no information provided about any major subcontractors. The DLA, a defense agency, is the funding agency for this contract.

Generated 3/31/25, 9:34 AM